• Can changes in EEG improve neuropathic pain treatments - read Oct newsletter.
  • Nine posters ready to reveal at the SfN virtual conference 8-11 Nov, booth 1818.
  • Joined-up preclinical and clinical trials to advance psilocybin drug development
  • Transpharmation joins HaPpY team to help break the vicious cycle of chronic pain & mood disorders, see News for details
  • Announcing new premises in Poland with a focus on neuropsychiatric disorders...
  • New state-of-the-art premises at Discovery Park, Kent

News you can use

Thanks for your interest in Transpharmation Ltd. We'd like to keep you updated on what's new and relevant. Please sign up to receive our newsletters, we won't bombard you or share your details with any other party and you can unsubscribe at any time.

Announcing Transpharmation Poland! Sent on 08 February 2020

The future's bright for the magic mushroom.

Expansion to world class premises Sent on 04 November 2020

We are delighted to share our very exciting news with you!In January 2021, Transpharmation Ltd will be taking on additional laboratory and office space, operating from the first-class facilities at the renowned Discovery Park research centre in Kent.This location will become Transpharmation’s primary site.

Multiple therapeutic indications Sent on 05 October 2020

Transpharmation Ltd celebrate 10 years in business. See our latest neuroinflammation study being presented at the Annual Alzheimer's Drug Discovery Foundation conference.

Focus on pain Sent on 04 September 2020

September is pain awareness month and we are presenting our latest pain study 'The effect of a reduced streptozocin dose and social housing on well-being, mechanical hypersensitivity and burrowing behaviour in type-1 diabetic rodents' at the IASP virtual conference.

Getting back out there safely Sent on 04 August 2020
New service - PBMC's Sent on 11 March 2020
Display #
Results 1 - 8 out of 8

Start a Conversation

preclinical +44 (0)203 633 2807

clinical trials +353 (0)1896 42 60

clinical research +48 515 244 120

EEG contact@transpharmation.co.uk

Copyright ©2021 Transpharmation Ltd. Website created by Identity Ipswich Web Design